Abiopharma

New Form DEFA14A - Vaxart, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028566 Size: 22 KB

New Form 144 - Enliven Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001974158-25-000057 Size: 5 KB

New Form 8-K - Qualigen Therapeutics, Inc. Filed: 2025-09-08 AccNo: 0001641172-25-026864 Size: 202 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Director Khattar Jack A. 🟡 adjusted position in 55.6K shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $46.01 ($6.3M) Transaction Date: Sep 05, 2025 | Filing ID: 000012

Bane Harrison R. 🔴 sold 9.3K shares of Surgery Partners, Inc. (SGRY) at $22.48 Transaction Date: Sep 04, 2025 | Filing ID: 000151

New Form 144 - SUPERNUS PHARMACEUTICALS, INC. Filed: 2025-09-08 AccNo: 0001950047-25-006856 Size: 10 KB

New Form 144 - Apellis Pharmaceuticals, Inc. Filed: 2025-09-08 AccNo: 0001969223-25-000743 Size: 6 KB

New Form 144 - INDIVIOR PLC Filed: 2025-09-08 AccNo: 0002007317-25-001045 Size: 5 KB

New Form 144 - Syndax Pharmaceuticals Inc Filed: 2025-09-08 AccNo: 0001950047-25-006849 Size: 5 KB

Johnson & Johnson - Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

New Form 144 - PTC THERAPEUTICS, INC. Filed: 2025-09-08 AccNo: 0001959173-25-005845 Size: 6 KB

New Form 144 - RESMED INC Filed: 2025-09-08 AccNo: 0001959173-25-005844 Size: 6 KB

New SEC Form for ResMed Inc.

New Form 8-K - BRUKER CORP Filed: 2025-09-08 AccNo: 0001140361-25-034295 Size: 1 MB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits